Viewing Study NCT06538857


Ignite Creation Date: 2025-12-24 @ 7:08 PM
Ignite Modification Date: 2026-01-24 @ 5:13 AM
Study NCT ID: NCT06538857
Status: RECRUITING
Last Update Posted: 2025-05-23
First Post: 2024-08-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: CEB-01 in Locally Resectable Pancreatic Cancer
Sponsor: CEBIOTEX
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Locally advanced disease View
None Resectable pancreatic cancer View
None Borderline resectable pancreatic cancer View